Regenicin Inc (RGIN):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Regenicin Inc (RGIN) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7901
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Regenicin Inc (Regenicin), formerly Windstar Inc is a biotechnology company that develops regenerative cell therapies. The company offers NovaDerm, a tissue-engineered skin prepared from autologous skin cells. Its NovaDerm technology uses the patient’s own skin cells to generate living, tissue-engineered skin for the treatment of severe burns. Regenicin offers banked allogenic cell products for treatment of chronic wounds, cosmetic and other topical testing, and medical testing services. The company develops products for diabetes and chronic wounds including ulcers, adult stem cell therapies and reconstructive surgical applications. It has operations throughout the US. Regenicin is headquartered in Little Falls, New Jersey, the US.

Regenicin Inc (RGIN) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Regenicin Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Regenicin Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Regenicin Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Regenicin Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Regenicin Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Regenicin Inc, Medical Equipment, Deal Details 10
Debt Offering 10
Regenicin Raises USD0.1 Million in Private Placement of 8% Note Due May 2014 10
Regenicin Raises USD0.3 Million in Private Placement of 8% Notes Due 2014 11
Regenicin Raises Funds through Private Placement of 8% Note Due November 2013 12
Regenicin Raises USD0.1 Million in Private Placement of 10% Note Due June 2013 13
Regenicin Raises USD0.1 Million in Private Placement of 10% Note Due January 2013 14
Regenicin Raises Funds through Private Placement of 33% Note Due October 2012 15
Regenicin Raises USD0.2 Million in Private Placement of 33% Note Due November 2012 16
Regenicin Raises USD0.2 Million in Private Placement of 33% Note Due 2012 17
Regenicin Raises USD0.1 Million in Private Placement of 8% Note Due March 2012 18
Regenicin Raises USD0.16 Million in Private Placement of 5% Note Due June 2012 19
Regenicin Inc – Key Competitors 20
Regenicin Inc – Key Employees 21
Regenicin Inc – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 23
Financial Announcements 23
Jan 18, 2017: Regenicin Reports 2016 Operating Results, Outlines Milestones for 2017 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
Regenicin Inc, Medical Equipment, Key Facts, 2017 2
Regenicin Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Regenicin Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Regenicin Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Regenicin Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Regenicin Inc, Deals By Market, 2012 to YTD 2018 8
Regenicin Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Regenicin Raises USD0.1 Million in Private Placement of 8% Note Due May 2014 10
Regenicin Raises USD0.3 Million in Private Placement of 8% Notes Due 2014 11
Regenicin Raises Funds through Private Placement of 8% Note Due November 2013 12
Regenicin Raises USD0.1 Million in Private Placement of 10% Note Due June 2013 13
Regenicin Raises USD0.1 Million in Private Placement of 10% Note Due January 2013 14
Regenicin Raises Funds through Private Placement of 33% Note Due October 2012 15
Regenicin Raises USD0.2 Million in Private Placement of 33% Note Due November 2012 16
Regenicin Raises USD0.2 Million in Private Placement of 33% Note Due 2012 17
Regenicin Raises USD0.1 Million in Private Placement of 8% Note Due March 2012 18
Regenicin Raises USD0.16 Million in Private Placement of 5% Note Due June 2012 19
Regenicin Inc, Key Competitors 20
Regenicin Inc, Key Employees 21
Regenicin Inc, Subsidiaries 22

List of Figures
Regenicin Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Regenicin Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Regenicin Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Regenicin Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Regenicin Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Regenicin Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Regenicin Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Regenicin Inc (RGIN):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • System Dynamics International Incorporated:企業の戦略・SWOT・財務分析
    System Dynamics International Incorporated - Strategy, SWOT and Corporate Finance Report Summary System Dynamics International Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • Olin Corp (OLN):企業の財務・戦略的SWOT分析
    Olin Corp (OLN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Petroleo Brasileiro SA (PETR4)-石油・ガス分野:企業M&A・提携分析
    Summary Petroleo Brasileiro S.A. (Petrobras) is an integrated oil and gas company. Its major businesses include exploration and production, refining, marketing , trade and transportation of oil and gas. The company also conducts biofuel, petrochemical, natural gas, electricity and chemical-gas busin …
  • Astrenska Insurance Ltd:企業の戦略・SWOT・財務情報
    Astrenska Insurance Ltd - Strategy, SWOT and Corporate Finance Report Summary Astrenska Insurance Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Valener Inc (VNR)-石油・ガス分野:企業M&A・提携分析
    Summary Valener Inc (Valener) is an investment holding company that focuses on the energy sector. Through its investment companies, the company offers storage, distribution, transportation and allied energy services. The company has interests in Gaz Metro and is its limited partner. Valener, through …
  • Lantern Pharma Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Lantern Pharma Inc (Lantern Pharma) is a clinical stage pharmaceutical company that discovers and develops therapies for various cancer types. The company’s pipeline products Irofulven-1 and Irofulven-2 are non-hormone, non-chemotherapy, next-generation DNA damage repair inhibitors. Its othe …
  • Micronics Inc:企業の製品パイプライン分析2018
    Summary Micronics Inc (Micronics) is a medical device company that develops and markets in vitro diagnostic products. The company provides products that include aborhcard and pannat system. Its research and development products comprise single-use, stand alone, disposable microfluidics-enabled cartr …
  • Senetas Corporation Limited:企業の戦略・SWOT・財務分析
    Senetas Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary Senetas Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Esprit Holdings Limited:企業の戦略・SWOT・財務分析
    Esprit Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Esprit Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Yum China Holdings Inc (YUMC):企業の財務・戦略的SWOT分析
    Yum China Holdings Inc (YUMC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Nano Intelligent Biomedical Engineering Corp (138610):医療機器:M&Aディール及び事業提携情報
    Summary Nano Intelligent Biomedical Engineering Corp (NIBEC) is a venture firm. The firm manufacture of tissue regeneration devices. It aims to research ideas for tissue regeneration treatments and to develop and manufacture devices for practical use. NIBEC offers bio fusion peptide-based products, …
  • Intertape Polymer Group Inc (ITP):企業の財務・戦略的SWOT分析
    Intertape Polymer Group Inc (ITP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • The Credit Mutuel-Cic Group:企業の戦略・SWOT・財務分析
    The Credit Mutuel-Cic Group - Strategy, SWOT and Corporate Finance Report Summary The Credit Mutuel-Cic Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Lazard Ltd:戦略・SWOT・企業財務分析
    Lazard Ltd - Strategy, SWOT and Corporate Finance Report Summary Lazard Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • IV Diagnostics Inc:医療機器:M&Aディール及び事業提携情報
    Summary IV Diagnostics Inc (IV Diagnostics) is a biomedical company that offers research services. The company conducts molecular diagnostic tests for circulating tumor cells and other blood borne diseases. It develops, tests and markets diagnostic tools that monitor and measure cancer tumor cells. …
  • Nuvelution Pharma Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Nuvelution Pharma Inc (Nuvelution Pharma) is a developer of late-stage clinical assets. The company offers research and development risk-sharing approach to pharmaceutical and biotechnology companies. It facilitates advancement of late-stage clinical assets where research and development bud …
  • SciBase AB (SCIB):医療機器:M&Aディール及び事業提携情報
    Summary SciBase AB (SciBase) is a medical technology company that offers non-invasive detection and monitoring of skin tissue alterations. The company develops point of care device for the accurate detection of malignant melanoma. It offers electrical impedance spectroscopy which uses the varying el …
  • SignPath Pharma Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary SignPath Pharma Inc (SignPath) is a developer of therapeutics based on its pure synthesized curcumin compounds. The company’s curcumin compounds acts as an anti-oxidant, anti-inflammatory and anti-cell recycling agent. It develops curcumin based products in different intravenous nanoparticle …
  • Guangzhou Wondfo Biotech Co Ltd (300482):製薬・医療:M&Aディール及び事業提携情報
    Summary Guangzhou Wondfo Biotech Co Ltd (Wondfo) is a biological company that develops, manufactures and supplies rapid diagnostic reagents and related equipment. Its products include rapid quantitative test, immunofluorescent test system, glucose monitoring system, and raw materials. Wondfo also of …
  • The AES Corporation (AES):電力:M&Aディール及び事業提携情報
    Summary The AES Corporation (AES) is a diversified power company, which owns and operates power generating facilities. The company generates electricity through diverse fuel sources such as gas, fuel oil and coal; and renewable sources such as wind, hydro, biomass and solar. It sells the electricity …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆